Exclusive collaboration and license agreement focuses on advancing novel T cell therapy “Seed-and-Boost” approach exploiting the mechanism of the CUE-100…
First large, randomized, placebo-controlled study to demonstrate clinical benefit in patients with Cold Urticaria (ColdU) and Symptomatic Dermographism (SD)All primary…
Society for Neuroscience Annual Meeting, November 15-19, San Diego, CAWALTHAM, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Sironax, a global…
SINGAPORE, Nov. 06, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical…
Quarterly Revenue Growth of 13% to ~$68 Million Gross Margin Increased to 43% on Improved Execution and Operational Efficiency Best-in-Class…
Company is progressing its previously initiated strategic review evaluating a range of options to maximize shareholder value, including assessment of…
Groundbreaking research using Nucleome MCC technology reveals complex structure of DNA inside living cells at base pair resolution for the…
SAN DIEGO and MONTPELLIER, France, Nov. 6, 2025 /PRNewswire/ -- Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates,…
HELSINKI, Nov. 6, 2025 /PRNewswire/ -- The world's leading innovation award, Millennium Technology Prize, will be awarded again in May…
New HIPPA-Compliant AI technology for Contract Modeling and Variance Analysis to Revolutionize Hospital Revenue Cycle Optimization WOODSTOCK, GA / ACCESS…